These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32210579)

  • 1. HANR Enhances Autophagy-Associated Sorafenib Resistance Through miR-29b/ATG9A Axis in Hepatocellular Carcinoma.
    Shi Y; Yang X; Xue X; Sun D; Cai P; Song Q; Zhang B; Qin L
    Onco Targets Ther; 2020; 13():2127-2137. PubMed ID: 32210579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-375 attenuates sorafenib resistance of hepatocellular carcinoma cells by inhibiting cell autophagy.
    Wang D; Yang J
    Acta Biochim Pol; 2023 Apr; 70(2):239-246. PubMed ID: 37068178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
    Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
    Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lncRNA NEAT1/miR-29b/Atg9a axis regulates IGFBPrP1-induced autophagy and activation of mouse hepatic stellate cells.
    Kong Y; Huang T; Zhang H; Zhang Q; Ren J; Guo X; Fan H; Liu L
    Life Sci; 2019 Nov; 237():116902. PubMed ID: 31610195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HANR promotes lymphangiogenesis of hepatocellular carcinoma via secreting miR-296 exosome and regulating EAG1/VEGFA signaling in HDLEC cells.
    Shi Y; Yang X; Xue X; Sun D; Cai P; Song Q; Zhang B; Qin L
    J Cell Biochem; 2019 Oct; 120(10):17699-17708. PubMed ID: 31127654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HANR Promotes Tumorigenesis and Increase of Chemoresistance in Hepatocellular Carcinoma.
    Xiao J; Lv Y; Jin F; Liu Y; Ma Y; Xiong Y; Liu L; Zhang S; Sun Y; Tipoe GL; Hong A; Xing F; Wang X
    Cell Physiol Biochem; 2017; 43(5):1926-1938. PubMed ID: 29055955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HANR promotes hepatocellular carcinoma progression via miR-214/EZH2/TGF-β axis.
    Shi Y; Yang X; Xue X; Sun D; Cai P; Song Q; Zhang B; Qin L
    Biochem Biophys Res Commun; 2018 Nov; 506(1):189-193. PubMed ID: 30342849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
    Li W; Dong X; He C; Tan G; Li Z; Zhai B; Feng J; Jiang X; Liu C; Jiang H; Sun X
    J Exp Clin Cancer Res; 2019 May; 38(1):183. PubMed ID: 31053148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy.
    Ma Z; Chen W; Liu Y; Yu L; Mao X; Guo X; Jiang F; Guo Q; Lin N; Zhang Y
    Autophagy; 2024 Mar; 20(3):541-556. PubMed ID: 37733919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIAA1429 mediates epithelial mesenchymal transition in sorafenib-resistant hepatocellular carcinoma through m6A methylation modification.
    Kuang Y; Cheng Y; Wang J; Li H; Cao X; Wang Y
    Cancer Med; 2023 Mar; 12(6):7222-7233. PubMed ID: 36420693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA SNHG16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5p.
    Ye J; Zhang R; Du X; Chai W; Zhou Q
    Onco Targets Ther; 2019; 12():415-422. PubMed ID: 30655679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line.
    Kaur R; Kanthaje S; Taneja S; Dhiman RK; Chakraborti A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-25 enhances autophagy and promotes sorafenib resistance of hepatocellular carcinoma via targeting FBXW7.
    Feng X; Zou B; Nan T; Zheng X; Zheng L; Lan J; Chen W; Yu J
    Int J Med Sci; 2022; 19(2):257-266. PubMed ID: 35165511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis.
    Feng J; Dai W; Mao Y; Wu L; Li J; Chen K; Yu Q; Kong R; Li S; Zhang J; Ji J; Wu J; Mo W; Xu X; Guo C
    J Exp Clin Cancer Res; 2020 Jan; 39(1):24. PubMed ID: 32000827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-101-3p sensitizes hepatocellular carcinoma cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.
    Sun W; Zhang Q; Wu Z; Xue N
    Int J Clin Exp Pathol; 2019; 12(6):2056-2065. PubMed ID: 31934027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy.
    Xu WP; Liu JP; Feng JF; Zhu CP; Yang Y; Zhou WP; Ding J; Huang CK; Cui YL; Ding CH; Zhang X; Lu B; Xie WF
    Gut; 2020 Jul; 69(7):1309-1321. PubMed ID: 31727683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-375 Targets ATG14 to Inhibit Autophagy and Sensitize Hepatocellular Carcinoma Cells to Sorafenib.
    Yang S; Wang M; Yang L; Li Y; Ma Y; Peng X; Li X; Li B; Jin H; Li H
    Onco Targets Ther; 2020; 13():3557-3570. PubMed ID: 32431510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HEIH Confers Cell Sorafenib Resistance in Hepatocellular Carcinoma by Regulating miR-98-5p/PI3K/AKT Pathway.
    Shen Q; Jiang S; Wu M; Zhang L; Su X; Zhao D
    Cancer Manag Res; 2020; 12():6585-6595. PubMed ID: 32821157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma.
    Dai F; Zhang Y; Chen Y
    Hum Pathol; 2014 Jun; 45(6):1285-93. PubMed ID: 24767251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
    Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
    Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.